Erik Karrer Email and Phone Number
Erik Karrer work email
- Valid
- Valid
- Valid
- Valid
Erik Karrer personal email
Erik Karrer phone numbers
Biotech professional with 20 years drug discovery experience. Demonstrated leadership in the areas of target discovery, drug discovery research, corporate strategy, heading departments and global project teams. Technical experience in human genetics based target discovery, molecular biology, protein engineering and technology innovation. Skilled at leading target and drug discovery teams in diverse therapeutic areas (NASH, fibrosis, autoimmunity, oncology, immuno-oncology, osteoarthritis, glaucoma, asthma, cardiovascular, endometriosis, pain). Project leadership experience in NASH, fibrosis, asthma, RA and transplantation areas. Successfully led two projects to IND. Strong communication, alliance management, team building and mentoring skills.
Character Biosciences
View- Website:
- characterbio.com
- Employees:
- 44
-
Character BiosciencesCharacter BiosciencesSan Francisco, Ca, Us
-
Svp, Drug DiscoveryCharacter Biosciences Dec 2022 - PresentSan Francisco, Ca, Us
-
Vp Drug DiscoveryCharacter Biosciences May 2022 - PresentSan Francisco, Ca, UsLeading human genetics-based target discovery and drug discovery research
-
Vp Drug DiscoveryClover Therapeutics Mar 2020 - Present
-
Director, Target Discovery23Andme Sep 2017 - Nov 2019Sunnyvale, California, Us-Leading evaluation of genetic and phenotypic data for identification of therapeutic drug targets and initiation of drug discovery programs -
Director, Drug Discovery23Andme Apr 2015 - Sep 2017Sunnyvale, California, Us-Scientific management of preclinical antibody therapeutics programs-Leading evaluation of drug target opportunities and initiation of drug discovery programs-Expanding technical and operational capabilities to support program advancement and portfolio expansion
-
Chief Scientific OfficerRuiyi Inc. Nov 2013 - Mar 2015Headed preclinical development- IL-6 antagonist antibody for treatment of RA in emerging markets - CB1 antagonist antibody for treatment of NASH/liver fibrosis and metabolic diseases (project lead) Headed discovery research- Led target evaluation and discovery of therapeutic antibodies against GPCR targets, initiated programs in pain and oncology Member of senior management team- Represented programs and technology to potential partners, investors and board of directors- Contributed to corporate strategy, advisory board and alliance management
-
Vice President, Molecular Biology And DiscoveryAstellas Pharma Jan 2011 - Aug 2013• Perseid senior management team - corporate strategy, integration into global Astellas organization• Head of Discovery - managing preclinical research portfolio, leading new drug concept evaluation• Member of global development core team - providing scientific leadership to early clinical programs• Molecular Biology Dept Head - leading application and expansion of protein engineering technologies• Member of Astellas Executive Leadership Series program - global executive leadership training
-
Senior Director, Molecular Biology And Drug DiscoveryPerseid Therapeutics Sep 2009 - Jan 2011Redwood City, Ca, Us• Member of Perseid senior management team - corporate strategy, successful acquisition by Astellas• Head of Discovery - managing preclinical research portfolio, leading new drug concept evaluation• Molecular Biology Dept Head - leading application and expansion of protein engineering technologies• Project Leader, CTLA4-Ig program - led project team to filing INDs in RA and transplantation -
Director, Drug Discovery; Maxy-4 Project LeaderMaxygen Oct 2008 - Sep 2009Sunnyvale, California, Us-Head of Discovery - scientific leadership to preclinical research portfolio and new product evaluation-Project Leader, CTLA4-Ig program - scientific and strategic leadership to multidisciplinary team-Represented assets to M&A candidates, ultimately co-founded Perseid Therapeutics LLC -
Senior ScientistMaxygen Aug 2006 - Oct 2008Sunnyvale, California, Us-Project Leader, next-gen CTLA4-Ig program-Represented program to potential partners, ultimately consummating co-development agreement with Astellas Pharmaceuticals
-
Staff Scientist IiiMaxygen Dec 2003 - Aug 2006Sunnyvale, California, Us-Project Leader, next-gen CTLA4-Ig program-Scientific contributions to cytokine research
-
Staff Scientist IiMaxygen Feb 1999 - Dec 2003Sunnyvale, California, UsALK-Abelló partner collaboration -Created recombinant protein vaccine candidates for the treatment of house dust mite allergies. DARPA grant - Created recombinant protein vaccine candidates to protect against bio-warfare agents.
-
Post-Doctoral FellowThe Scripps Research Institute May 1997 - Oct 1998La Jolla, California, UsDr. Dennis Burton, principle investigator- Created Fab phage display libraries from the immune repertoire of HIV-positive long-term non-progressor patients. -
Post-Doctoral FellowThe Scripps Research Institute Aug 1994 - Apr 1997La Jolla, California, UsNIH Research Fellowship Grant. Dr. Roger Beachy, principle investigator- Identified and cloned tobacco genes that elicit the hypersensitive response (HR).
-
Post-Doctoral FellowCeprap (A National Science Foundation Center) Aug 1992 - Aug 1994Dr. Danny Alexander, principle investigator- Developed a novel method to create cDNA libraries from individual plant cells.
-
Research AssistantUc Davis Sep 1989 - Sep 1992Davis, California, UsDr. Raymond Rodriguez, principle investigator- Characterized the temporal and spatial expression of the rice and barley alpha-amylase gene families. Discovered a novel mechanism of alpha-amylase gene regulation.
Erik Karrer Skills
Erik Karrer Education Details
-
University Of California, DavisGenetics -
University Of California, DavisGenetics
Frequently Asked Questions about Erik Karrer
What company does Erik Karrer work for?
Erik Karrer works for Character Biosciences
What is Erik Karrer's role at the current company?
Erik Karrer's current role is Character Biosciences.
What is Erik Karrer's email address?
Erik Karrer's email address is er****@****ics.com
What is Erik Karrer's direct phone number?
Erik Karrer's direct phone number is (800) 239*****
What schools did Erik Karrer attend?
Erik Karrer attended University Of California, Davis, University Of California, Davis.
What skills is Erik Karrer known for?
Erik Karrer has skills like Drug Discovery, Immunology, Biotechnology, Molecular Biology, Protein Chemistry, Protein Engineering, Clinical Development, Antibodies, Life Sciences, Cell Culture, Phage Display, Pharmaceutical Industry.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial